CARA Announces Exploration of Strategic Alternatives查看全文
Cara Therapeutics(CARA)06-07 04:35
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015763 Size: 7 KB 网页链接查看全文
Cara Therapeutics(CARA)06-07 04:35
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015765 Size: 7 KB 网页链接查看全文
Cara Therapeutics(CARA)07-09 04:35
$Cara Therapeutics(CARA)$ SC 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001086364-24-008232 Act: 34 Size: 12 KB 网页链接查看全文
Cara Therapeutics(CARA)06-13 05:15
$Cara Therapeutics(CARA)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-070914 Act: 34 Size: 223 KB 网页链接查看全文
Cara Therapeutics(CARA)06-08 04:15
$Cara Therapeutics(CARA)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001104659-24-069625 Act: 34 Size: 230 KB 网页链接查看全文
Cara Therapeutics(CARA)06-08 04:15
$Cara Therapeutics(CARA)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-069643 Act: 33 Size: 39 KB 网页链接查看全文
Cara Therapeutics(CARA)06-07 04:25
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015756 Size: 7 KB 网页链接查看全文
Cara Therapeutics(CARA)05-14 04:15
$Cara Therapeutics(CARA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-060529 Act: 34 Size: 285 KB 网页链接查看全文
Cara Therapeutics(CARA)05-14 04:25
$Cara Therapeutics(CARA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007964 Act: 34 Size: 8 MB 网页链接查看全文
相信Myself2015-03-12 03:06
$CARA THERAPEUTICS(CARA)$像这种sell stop被打掉,又将近是全天最低价的,如果你对此麻木了,恭喜。如果让人极度不爽的话,那是修行未够。。。我暂时是后者。查看全文
中本蒜2015-01-04 11:32
$CARA THERAPEUTICS(CARA)$ CR845镇痛但不成瘾。如果三期顺利,可望取得FDA最低类管制药物甚至是非管制药物。这不得了。这是game changer查看全文
中本蒜2015-01-04 11:23
$CARA THERAPEUTICS(CARA)$ 药看起来是个好东西。CEO是做技术的人。现在有几个二期和几个一期试验。效果都不错。可买入等待三期试验结果。查看全文
格隆汇3月7日丨Cara Therapeutics(CARA.US)盘前跌31.14%,报6.9美元。公司2022年Q4财报实现营收326.1万美元,预期值为1625万美元,比市场预期低79.93%;每股收益为-0.56美元,预期值为-0.32美元,... 网页链接
$Cara Therapeutics(CARA)$ SC 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001086364-24-008232 Act: 34 Size: 12 KB 网页链接
$Cara Therapeutics(CARA)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-070914 Act: 34 Size: 223 KB 网页链接
$Cara Therapeutics(CARA)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001104659-24-069625 Act: 34 Size: 230 KB 网页链接
$Cara Therapeutics(CARA)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-069643 Act: 33 Size: 39 KB 网页链接
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015763 Size: 7 KB 网页链接
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015765 Size: 7 KB 网页链接
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015751 Size: 7 KB 网页链接
$Cara Therapeutics(CARA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015756 Size: 7 KB 网页链接
$Cara Therapeutics(CARA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007964 Act: 34 Size: 8 MB 网页链接
$Cara Therapeutics(CARA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-060529 Act: 34 Size: 285 KB 网页链接